spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

5th Annual Peptides Congress 2018

Oxford Global - Peptides Congress

16-17 April 2018
Novotel London West Hotel, Hammersmith, London

Oxford Global Conferences are proud to present our highly anticipated 5thAnnual Peptides Congress, 16th – 17th April 2018, London, UK. Over 450 peptides, proteins and antibodies attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

Over 25 presentations and case studies focused on the key advancements in peptides technologies, peptide therapeutics as well as chemistry and delivery

Two-day interactive conference addressing three main themes:

  • Peptide Research, Chemistry and Analytical Technologies
  • Peptide Therapeutics
  • Peptide Discovery, Manufacturing and Delivery

Co-located with the 

11th Annual Proteins & Antibodies Congress and 

5th Biennial Biosimilars & Biobetters Congress.

View the Agenda here:

http://bit.ly/2xvl8TX


Free Pre-Congress Live Webinars

From Peptide Discovery to Phase 3 – A Zealand Perspective
Wednesday 7th February 2018 | 3pm GMT
Andy Parker, Senior Vice President and Chief Scientific Officer, Zealand Pharma

Register today for free: 

http://bit.ly/2uQ2XuA 

Improved Non-Invasive Routes of Administration of Peptides

Wednesday 7th February 2018 | 2pm GMT

Joël Richard, Senior Vice President, Peptides, Head of CMC Development Dreux Site, Ipsen  

Register today for free: 

http://bit.ly/2uQ2XuA 

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact g.alonso@oxfordglobal.co.uk


phone +44 (0)1865 248455
email info@oxfordglobal.co.uk
web bit.ly/2irNdsH
email Oxford Global Ltd, Part 1st Floor, Godstow Court, Minns Business Park, Botley, Oxford, OX2 0J
 
Print this page
Send to a friend
   
spacer
Industry Events

3rd Annual Inhalation & Respiratory Drug Delivery Congress

8-9 May 2018, London, UK

Oxford Global are proud to present our hugely popular 3rd Annual Inhalation & Respiratory Drug Delivery Congress, 8th – 9th May 2018, London, UK. Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will gather for over 20 presentations and case studies focused on the key issues in inhalation and respiratory drug delivery.
More info >>

Banner of OCT Medical Devices Europe 2018_events_95 on Samedan Banner of 3D_Cell_Culture_events_97 on Samedan

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>


News and Press Releases

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

November 16, 2017, Oxford, England and San Francisco, US. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast™ technology platform to provide a broad range of application-specific expression vectors which Twist Bioscience will use to clone synthesized DNA for its diverse customer base.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement